• RotaChrom CPC Instruments & Solutions
  • Technology
  • About Us
  • FAQ
  • Blog
  • Webinars
  • Podcasts
  • Pressroom
  • Contact
Here you can see the logo of RotaChrom Technologies.
Here you can see the logo of RotaChrom Technologies.
  • Products
    • CPC Modeler
    • GMP rCPC
    • rCPC
    • iCPC
    • Continuous CPC
    • pCPC
    • SKIDS
  • Pricing
  • Technology
  • Applications
    • Pharma and biotech
    • Cosmetics and Fragrances
    • Food and Beverages
    • Botanical applications
  • Calculator
  • Company
    • About Us
    • Events
  • Resources
    • Blog
    • Webinars
    • Publications
    • Pressroom
    • FAQ
    • Podcasts
  • Contact
    • Career
    • Contact
    • Book a meeting

Evolution of Cannabis Classification: A Modern Perspective

January 10, 2024
In Education, News
Share via Share via Share via Share via

For millennia, cannabis has served medicinal purposes. In the 18th century, the classification of cannabis into Indica, Sativa, and sometimes Ruderalis emerged for commercial use, gaining popularity among recreational users. However, contemporary scientists challenge this outdated system, especially in medical contexts. Instead of relying on plant types, a more pertinent approach involves assessing CBD and THC levels and the types of terpenes in cannabis flowers, enabling a more accurate classification for medical use.

Cannabis, Endocannabinoid System, and Phytocannabinoids

The endocannabinoid system (ECS) functions as a regulatory framework with receptors interacting with endogenous cannabinoids, influencing physiological processes like pain perception, emotional regulation, sleep patterns, and immune system function. Phytocannabinoids from the cannabis plant, including THC and CBD, can also bind to these receptors, producing similar effects. Key receptors, CB1 and CB2, widely distributed throughout the body, contribute to analgesic effects.

Pain Management with Cannabis

Cannabis emerges as a valuable tool in pain management, offering a complementary approach alongside conventional pain relievers like opioids. For patients with inadequate relief from standard treatments or facing opioid-related side effects, cannabinoid therapy presents a promising alternative. This approach may lead to reduced opioid dosages, minimizing side effects and dependency risks.

Cannabinoids Alleviating Side Effects:

  • Nausea and Vomiting: Cannabis treatment during chemotherapy shows potential in mitigating opioid-induced nausea and vomiting.
  • Appetite Stimulation: Cannabis can counteract appetite loss and weight reduction associated with severe pain and opioid therapy.
  • Depression: Studies indicate cannabis prescriptions for addressing depression in chronic pain patients.
  • Sleep Disorders: Medical cannabis may have a sleep-promoting effect, offering relief from sleep disturbances associated with chronic pain.

Recent studies highlight the intricate effects of the cannabis plant. Relying solely on visual cues of cannabis flowers for therapeutic decisions oversimplifies the process. More research is crucial to accurately predict the effects of different strains based on their specific chemical makeup. The complexity of the plant underscores the need for a nuanced understanding in guiding therapeutic choices.

Previous article
Centrifugal Partition Chromatography (CPC): A Sustainable Paradigm Shift
Next article
Navigating the Chromatography Journey: A Comprehensive Guide to Process Steps

Related News

Other posts that you should not miss.
ILMAC 2023 Crew

ILMAC 2023: Meet Our Team and Learn About Chromatography

September 1, 2023
-
Conferences, Events, Exhibitions, News
Where to Meet RotaChrom at ILMAC 2023? Our lovely team is looking forward to meet you at ILMAC 2023! If you'd like to shake hands with them and…
Read More →
4 MIN READ

Enhancing API Manufacturing with Contract Development and Manufacturing Organizations (CDMOs) and Industrial-Scale Centrifugal Partition Chromatography (CPC)

May 15, 2024
-
Education, News
The manufacturing of small molecule Active Pharmaceutical Ingredients (APIs) is a multifaceted process requiring specialized facilities, regulatory expertise, and scientific acumen. To navigate this complex landscape, pharmaceutical innovators…
Read More →
3 MIN READ
Chemspec Header

Here Is Your Missing Allrounder for Purification: CPC – RotaChrom at Chemspec

March 20, 2023
-
Conferences, News
BOOK A MEETING AT CHEMSPEC! Click here to book a meeting with our Chief Product Officer, Andras Gaspar. See you at Chemspec 2023! Chemspec Europe is a highly…
Read More →
3 MIN READ

Latest News

Increasing separation efficiency by pH adjustment in Centrifugal Partition Chromatography

May 19, 2025 – News

Addressing pH Issues in Chromatography: From Solid-Phase to Liquid-Liquid Separations

May 15, 2025 – Education, News

Chemspec 2025

May 15, 2025 – Conferences, Education, Exhibitions, News

Advancing Separation Science: CPC Device Installation and Its Impact

April 17, 2025 – News

Webinars

Separation of Remdesivir Diastereomeres by Centrifugal Partition Chromatography

September 25, 2023

Green Features of Centrifugal Partition Chromatography

May 10, 2021

Contact Us

RotaChrom Technologies PLC (Headquarters)

Csillag street 2/A, Kecskemet, HU-6000

+36 70 885 6922

RotaChrom North America Inc.

300 Spectrum Center Drive, Irvine, CA 92618

+1 (720) 220-5669

Cookie Policy  /  Data Protection Policy  /  RotaChrom® is a registered trademark of Rotachrom Technologies in the USA and EU. / © 2025 RotaChrom Technologies. All rights reserved.
Evolution of Cannabis Classification: A Modern Perspective - Rotachrom Technologies